LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 79.34 | 84.90 | 3085 | 9051 | 0.3408 | 0.7047 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 79.34 | 84.90 | 3116 | 9051 | 0.3443 | 0.7072 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 79.34 | 84.90 | 3653 | 9051 | 0.4036 | 0.7480 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 79.34 | 84.90 | 3696 | 9051 | 0.4083 | 0.7510 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 81.05 | 84.90 | 3135 | 8863 | 0.3537 | 0.7129 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 81.05 | 84.90 | 3162 | 8863 | 0.3567 | 0.7150 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 81.05 | 84.90 | 3762 | 8863 | 0.4244 | 0.7601 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 81.05 | 84.90 | 3815 | 8863 | 0.4304 | 0.7637 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.75 | 84.90 | 3303 | 8621 | 0.3831 | 0.7319 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.75 | 84.90 | 3328 | 8621 | 0.3860 | 0.7339 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.75 | 84.90 | 3837 | 8621 | 0.4451 | 0.7713 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 82.75 | 84.90 | 3885 | 8621 | 0.4506 | 0.7746 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.45 | 84.90 | 3376 | 8254 | 0.4090 | 0.7467 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.45 | 84.90 | 3409 | 8254 | 0.4130 | 0.7493 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.45 | 84.90 | 4008 | 8254 | 0.4855 | 0.7927 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 84.45 | 84.90 | 4061 | 8254 | 0.4920 | 0.7963 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.16 | 84.90 | 3458 | 8141 | 0.4247 | 0.7561 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.16 | 84.90 | 3483 | 8141 | 0.4278 | 0.7580 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.16 | 84.90 | 4182 | 8141 | 0.5136 | 0.8075 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 86.16 | 84.90 | 4223 | 8141 | 0.5187 | 0.8102 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.86 | 84.90 | 3591 | 7680 | 0.4676 | 0.7792 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.86 | 84.90 | 3622 | 7680 | 0.4716 | 0.7816 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.86 | 84.90 | 4313 | 7680 | 0.5616 | 0.8301 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.86 | 84.90 | 4363 | 7680 | 0.5681 | 0.8333 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 89.57 | 84.90 | 3712 | 7494 | 0.4953 | 0.7940 | MN20160318_Q02 | C11 |